Aurinia Pharmaceuticals Inc. (AUPH) - Dilution Analysis

Visualizing historical and potential share dilution over time

View Stock Details

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Dilution Analysis

Low Risk

Limited dilution potential

Last updated: May 07, 2026

Risk Assessment Details

Potential Dilution: 9.03% of current shares

Recent Dilution: 0.43% (2 years)

Historical Dilution Factor: minimal recent dilution

Outstanding Shares

130M

Potential Supply

12M

Additional shares possible

Splits

None

Past 2 years

Summary

AUPH currently has 132M outstanding shares. with limited dilution risk as only 12M additional shares (9.0%) are authorized for issuance. The company has minimally diluted shareholders by 0.43% over the past 2 years.

Share Structure Timeline

Outstanding Shares

Total Supply

Historical Data Points

Date	Event	Outstanding	Supply
May 07, 2026	10-Q filing \| 132.4M shares outstanding	130M	12M
Nov 04, 2025	10-Q filing \| 131.8M shares outstanding	130M	13M
Jul 31, 2025	10-Q filing \| 134.9M shares outstanding	130M	9.5M
May 12, 2025	10-Q filing \| 138.9M shares outstanding	140M	5.4M
Feb 27, 2025	10-K filing \| 143.1M shares outstanding	140M	1.3M
Nov 07, 2024	10-Q filing \| 143.1M shares outstanding	140M	1.3M
Aug 01, 2024	10-Q filing \| 143.3M shares outstanding	140M	1M
May 02, 2024	10-Q filing \| 144.0M shares outstanding	140M	320K
Feb 15, 2024	10-K filing \| 143.2M shares outstanding	140M	1.1M
Nov 02, 2023	10-Q filing \| 142.8M shares outstanding	140M	1.5M
Aug 03, 2023	10-Q filing \| 142.8M shares outstanding	140M	1.6M
May 04, 2023	10-Q filing \| 142.6M shares outstanding	140M	1.7M
Feb 28, 2023	10-K filing \| 141.9M shares outstanding	140M	2.4M
Nov 03, 2022	10-Q filing \| 141.9M shares outstanding	140M	2.5M
Aug 04, 2022	10-Q filing \| 141.7M shares outstanding	140M	2.6M
May 10, 2022	10-Q filing \| 141.7M shares outstanding	140M	2.7M
Feb 28, 2022	10-K filing \| 141.7M shares outstanding	140M	2.7M
Nov 03, 2021	10-Q filing \| 128.4M shares outstanding	130M	16M
Aug 05, 2021	10-Q filing \| 128.2M shares outstanding	130M	16M
May 06, 2021	10-Q filing \| 128.2M shares outstanding	130M	16M
Feb 24, 2021	10-K filing \| 127.5M shares outstanding	130M	17M
May 29, 2020	F-10 filing: Aurinia Pharmaceuticals Inc. is filing a short form base shelf prospectus for the issue and sale of common shares, warrants, subscription receipts, debt securities, convertible securities, and units up to US$500,000,000.	110M	33M
Mar 05, 2020	40-F filing \| 111.8M shares outstanding	110M	0

Back to AUPH Details